Association between Lipid Profile Limitations and Blood Glucose Values among Obese Adult Men in South Babylon Province, Iraq
Article Sidebar
Abstract
A main community health alarm, obesity is carefully related with metabolic syndromes for example, dyslipidemia and insulin resistance. This study aimed to assess the correlation between lipid profile limitations and fasting blood glucose values in an obese adult male in south Babylon province, Iraq. 60 adult male’s individuals in a case-control investigation, including 30 obese individuals (BMI ≥ 30 kg/m²) and 30 age-matched, healthy, non-obese controls. Blood glucose, total cholesterol, triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very-low-density lipoprotein (VLDL) were evaluate using conventional enzymatic colorimetric methods. The fasting blood glucose values of the obese and control groups did high significant different, according to the data (P<0.0001). Conversely, obese individual had significantly lower HDL values (P < 0.0001) and significantly higher values of total cholesterol, (TG, LDL, and VLDL). BMI was significantly positively correlated with TG, total cholesterol, and VLDL, whereas it was significantly negatively correlated with HDL. There was no correlation between fasting blood glucose and cholesterol limits or BMI. In conclusion, even in the absence of hyperglycemia, obesity in adult males is closely allied with negative changes in their lipid profiles. The consequences of this study highlight the significance of lipid profiles as early signs of metabolic risk in obese individuals in addition to the requirement for early interventions to reduce metabolic and cardiovascular problems.
Full text article
References
Albuquerque, D., Nóbrega, C., Manco, L., & Padez, C. (2017). The contribution of genetics and environment to obesity. British medical bulletin, 123(1), 159-173.
Alfaris, N., Alqahtani, A. M., Alamuddin, N., and Rigas, G. (2023). Global impact of obesity. Gastroenterology Clinics, 52(2), 277-293.
Baneu, P., Văcărescu, C., Drăgan, S. R., Cirin, L., Lazăr-Höcher, A. I., Cozgarea, A., ... and Cozma, D. (2024). The triglyceride/HDL ratio as a surrogate biomarker for insulin resistance. Biomedicines, 12(7), 1493.
Chooi, Y. C., Ding, C., and Magkos, F. (2019). The epidemiology of obesity. Metabolism, 92, 6-10.
Cochran, B. J., King, T. W., Chemello, K., Thomas, S. R., and Rye, K. A. (2025). HDL metabolism and function in diabetes mellitus. Nature Reviews Endocrinology, 1-14.
Grundy, S. M. (2016). Metabolic syndrome update. Trends in cardiovascular medicine, 26(4), 364-373.
Islam, M. R. (2025). Metabolic syndrome as a nexus of diabetes and cardiovascular disease: pathophysiological insights, epidemiological evidence, and therapeutic implications (Doctoral dissertation, Laurentian University Library and Archives).
Jahdkaran, M., and Sistanizad, M. (2025). From lipids to glucose: investigating the role of dyslipidemia in the risk of insulin resistance. The Journal of Steroid Biochemistry and Molecular Biology, 106744.
Kovács, N., Shahin, B., Andrade, C. A. S., Mahrouseh, N., and Varga, O. (2024). Lifestyle and metabolic risk factors, and diabetes mellitus prevalence in European countries from three waves of the European Health Interview Survey. Scientific Reports, 14(1), 11623.
Le, T. K. C., Dao, X. D., Nguyen, D. V., Luu, D. H., Bui, T. M. H., Le, T. H., and Nguyen, T. T. T. (2023). Insulin signaling and its application. Frontiers in endocrinology, 14, 1226655.
Lozano, A. A., Malvar, W. J. D., Mana, B. A. B., Mercado, F. A. V., Queddeng, M. B., Tejano, A. S. P. P., & Florentino, C. M. (2023). Effect of Centrifugation Speed and Time on the Blood Chemistry Values of Healthy Individuals. The Vector: International Journal of Emerging Science, Technology and Management (IJESTM), 32(1).
Nussbaumerova, B., and Rosolova, H. (2023). Obesity and dyslipidemia. Current atherosclerosis reports, 25(12), 947-955.
Poirier, P., and Eckel, R. H. (2002). Obesity and cardiovascular disease. Current atherosclerosis reports, 4(6), 448-453.
Pownall, H. J., and Gotto Jr, A. M. (2019). Lipids and cardiovascular disease: putting it all together. Methodist DeBakey cardiovascular journal, 15(1), 5.
Rashid, M., et al. (2023). Correlation of Body Mass Index with Serum Lipid Profile Level in Adolescent Students of Bangladesh. Journal of Clinical & Diagnostic Research. PMID:38944735.
Salam, M. M., Yousuf, R., Salam, M. W., and Haque, M. (2023). Obesity and overweight: A global public health issue. Advances in Human Biology, 13(1), 154-156.
Shetty, S., Suvarna, R., Bhattacharya, S., and Seetharaman, K. (2025). Visceral adiposity and Cardiometabolic risk: clinical insights and assessment. Cardiology in Review, 10-1097.
Singla, P., Bardoloi, A., and Parkash, A. A. (2010). Metabolic effects of obesity: a review. World journal of diabetes, 1(3), 76.
Smith, J. D., et al. (2010). Association of body mass index and lipid profiles: evaluation of a broad spectrum of body mass index patients including the morbidly obese. Obesity Research & Clinical Practice. PMID:20563664.
Tall, A. R., Thomas, D. G., Gonzalez-Cabodevilla, A. G., and Goldberg, I. J. (2022). Addressing dyslipidemic risk beyond LDL-cholesterol. The Journal of clinical investigation, 132(1).
World Health Organization (WHO) (2022). Obesity and Overweight. http://www.who.int/mediacentre/factsheets/fs311/en/.
Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.